The Cooper Companies, Inc. (NASDAQ:COO) Position Trimmed by Victory Capital Management Inc.

Victory Capital Management Inc. decreased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 0.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,519,264 shares of the medical device company’s stock after selling 5,754 shares during the period. Victory Capital Management Inc. owned 2.26% of Cooper Companies worth $381,200,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of COO. Mirae Asset Global Investments Co. Ltd. raised its stake in Cooper Companies by 15.1% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company’s stock valued at $2,194,000 after acquiring an additional 3,440 shares in the last quarter. DAVENPORT & Co LLC grew its holdings in shares of Cooper Companies by 13.4% in the 1st quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company’s stock worth $366,000 after acquiring an additional 513 shares during the last quarter. State of Alaska Department of Revenue raised its holdings in shares of Cooper Companies by 3.0% during the first quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company’s stock valued at $1,972,000 after acquiring an additional 680 shares during the period. Proficio Capital Partners LLC acquired a new stake in Cooper Companies during the 4th quarter worth about $95,000. Finally, Cetera Investment Advisers increased its stake in shares of Cooper Companies by 1.3% in the fourth quarter. Cetera Investment Advisers now owns 24,049 shares of the medical device company’s stock worth $2,211,000 after acquiring an additional 312 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

COO has been the topic of several recent research reports. Wall Street Zen lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Saturday. Loop Capital set a $100.00 price objective on shares of Cooper Companies in a report on Tuesday, June 17th. Piper Sandler reiterated an “overweight” rating and issued a $105.00 price objective (down previously from $115.00) on shares of Cooper Companies in a research report on Friday, May 30th. Needham & Company LLC raised Cooper Companies from a “hold” rating to a “buy” rating and set a $94.00 target price for the company in a research report on Tuesday, June 17th. Finally, Robert W. Baird dropped their price objective on shares of Cooper Companies from $107.00 to $97.00 and set an “outperform” rating for the company in a research note on Friday, May 30th. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $99.70.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $72.20 on Wednesday. The Cooper Companies, Inc. has a 1-year low of $65.00 and a 1-year high of $112.38. The firm’s 50-day moving average price is $74.59 and its two-hundred day moving average price is $82.37. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $14.44 billion, a price-to-earnings ratio of 35.05, a P/E/G ratio of 1.80 and a beta of 0.99.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The firm had revenue of $1 billion during the quarter, compared to analysts’ expectations of $995.12 million. During the same quarter last year, the company posted $0.85 EPS. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. On average, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.